Search results
Added:
3 years ago
Cardiovascular Magnetic Resonance in Ischemic Heart Disease
Left Ventricular Structure and Function at Rest
The most fundamental quantitative measurements of the heart include those of ventricular size and function. Due to its high spatial and temporal resolution and the freedom to image in any plane, cardiovascular magnetic resonance (CMR) imaging is especially suited for this task…
View more
Added:
6 months ago
Source:
Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen
The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in…
View more
Added:
3 years ago
Cardiovascular Magnetic Resonance in Ischemic Heart Disease
Left Ventricular Structure and Function at Rest
The most fundamental quantitative measurements of the heart include those of ventricular size and function. Due to its high spatial and temporal resolution and the freedom to image in any plane, cardiovascular magnetic resonance (CMR) imaging is especially suited for this task…
View more
Added:
3 years ago
Acute decompensated heart failure (ADHF) is a syndrome defined by worsening fatigue, dyspnea, or edema that results from deteriorating heart function and usually leads to hospital admission or unscheduled medical intervention.1 Among patients over 65 years of age it remains the leading cause of hospital admission (>1 million admissions per year in the US alone), has an exceptionally high rate…
View more
Added:
6 years ago
In this video Dr Ajay Kirtane discusses the way in which DEFINE-FLAIR has affected his clinical practice.
View more
Added:
3 years ago
Contrast-induced nephropathy (CIN) represents an increasing healthcare burden and challenge as the frequency of diagnostic imaging and interventional studies increase, particularly among populations at risk of developing CIN. As the population ages, decreased renal function and increased atherosclerotic cardiovascular disease become more prevalent. Increasing levels of obesity with resultant…
View more
Added:
4 years ago
Dr Marc P Bonaca (University of Colorado, Aurora, US) and Prof Roxana Mehran (Mount Sinai Hospital, New York, US) discuss the latest Clinical Data Update on TWILIGHT and TWILIGHT-ACS.
This video is a segment from a wider wrap-up of data presented at AHA 2019 on Antithrombotics. The full discussion can be viewed at https://www.radcliffecardiology.com/AHA-2019-Clinical-Data-Update-on-Ant...
…
View more
Added:
3 years ago
Heart failure (HF) is a major health problem and about 6 million adults are affected in the US alone, at a cost of approximately $20 billion per year.1 Despite the availability of new treatment strategies, the incidence, number of hospitalizations and mortality associated with HF remains a big health burden.1 In addition to increasing age, the factors that contribute to poor prognosis for people…
View more
Added:
3 years ago
Although less common than other forms of cardiomyopathy, cardiac sarcoidosis (CS), both as part of a systemic process and in its isolated form, is an important, and increasingly recognized disorder. This is felt to be due, in part, to advances in cardiac imaging and heightened awareness of the disorder.1,2 CS is associated with high rates of morbidity and mortality, including sudden cardiac death…
View more
Added:
1 year ago
AHA 22 - CardioNerds Fellow, Dr Kahtan Fadah(Texas Tech University, US) is joined by PREVENT-HD PI, Dr Gregory Piazza (Brigham and Women's Hospital, US) to discuss the findings revealed at AHA 2022.
PREVENT-HD was designed to evaluate the safety and efficacy of rivaroxaban in reducing the risk of major venous and arterial thrombotic events in patients with COVID-19. Over 1200 patients were…
View more
« First